MARKET

GTBP

GTBP

Gt Biopharma Inc
NASDAQ
0.3939
-0.0450
-10.25%
After Hours: 0.3941 +0.0002 +0.05% 19:56 05/15 EDT
OPEN
0.4508
PREV CLOSE
0.4389
HIGH
0.4641
LOW
0.3750
VOLUME
4.01M
TURNOVER
--
52 WEEK HIGH
3.850
52 WEEK LOW
0.2610
MARKET CAP
12.43M
P/E (TTM)
-0.0630
1D
5D
1M
3M
1Y
5Y
1D
GT Biopharma Records Q1 Loss Of $2 Mln; Advances GTB-3650 In Phase 1 Trial For Leukemia
NASDAQ · 18h ago
GT Biopharma reports Q1 results
Seeking Alpha · 21h ago
GT Biopharma Q1 EPS $(0.11) Misses $(0.08) Estimate
Benzinga · 21h ago
GT Biopharma Q2 FY26 net loss widens to $2.8 million
PUBT · 22h ago
*GT Biopharma 1Q Loss $2.8M >GTBP
Dow Jones · 22h ago
*GT Biopharma: Cash Runway Through 4Q 2026 >GTBP
Dow Jones · 22h ago
GT BIOPHARMA REPORTS FIRST QUARTER 2026 FINANCIAL RESULTS
Reuters · 22h ago
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga · 1d ago
More
About GTBP
GT Biopharma, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of immuno-oncology therapeutic products based on its proprietary Tri-specific Killer Engager (TriKE) natural killer (NK) cell engager platform. Its TriKE platform is designed to harness and enhance the cancer-killing abilities of a patient’s immune system’s natural killer cells. Its product candidate pipeline includes GTB-3550, GTB-3650, GTB-5550, GTB-7550, GTB-6550, GTB-1050, and other product candidates. GTB-3550 is a TriKE comprised of two single-chain variable fragments (scFv) composed of the variable regions of the heavy and light chains of anti-CD16 and anti-CD33 antibodies and a modified form of IL-15. GTB-3650 is a TriKE which targets CD33 on the surface of myeloid leukemias. The Company also has a worldwide license agreement with the University of Minnesota to further develop and commercialize therapies using TriKE technology.

Webull offers GT Biopharma Inc stock information, including NASDAQ: GTBP real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, GTBP stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading GTBP stock methods without spending real money on the virtual paper trading platform.